DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Fosun Pharma
Fosun Pharma
Annual Report
Biontech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine
ACAL China Equity Nov17
Hang Seng Indexes Announces Index Review Results
China Pharmaceuticals China Pharmaceuticals Spring Is in the Air – We Expect a Year of Healthy Growth
股 份 有 限 公 司 Shanghai Fosun Pharmaceutical (Group) Co
Annual Report 2020 03 Corporate Information
Hang Seng Indexes Announces Index Review Results of Hang Seng Corporate Sustainability Index Series
上海復星醫藥(集團)股份有限公司 Shanghai Fosun Pharmaceutical
China Healthcare
上海復星醫藥(集團)股份有限公司 Shanghai Fosun Pharmaceutical
Securities Margin Shares Pledged List
Annual Report 2010
集團 )股份有限公司 Shanghai Fosun Pharmaceutical (Group
Fosun Pharma Inks Agreement with Biontech for COVID-19 Vaccine Supply in China
Strategy Report Hong Kong Equity Research
Shanghai Fosun Pharmaceuticals (Group) Company Limited
Following Money: China Inc's Growing Stake on China-India Relations
Top View
Fosun International Limited
China Focus@Europe Vienna 2019
China Inc in India, 2000-2018: from State-Led to Market-Driven
上海復星醫藥(集團)股份有限公司 Shanghai Fosun Pharmaceutical
上海復星醫藥(集團)股份有限公司 Shanghai Fosun Pharmaceutical
ANNUAL REPORT 2014(H Shares)
List of Hk Marginable Securities
LGIM ESG Scores
Securities Margin Loanable Securities List
Annual Report 2018
Interim REPORT 2020
2019 ANNUAL Report
List of Bond Connect Securities 2021-09-01
Shanghai Fosun Pharmaceutical (Group) Co., Ltd
Interim Report
Sino Biopharmaceutical 1177.HK, 1177 HK Top Pharma Player Yet Near Term Cloudy Outlook; Price: HK$5.36 Neutral Price Target: HK$5.00
China Everbright Limited to Jointly Acquire U.S. Innovative Biotechnology Company Ambrx
Securities Margin List (Effective from 11Th Jun 2021)